NASDAQ · Medical - Devices

LIVN (LIVN) Stock

$81.43 -0.80% NASDAQ: LIVN Healthcare

Valuation

MetricValue
Price$81.43
Market Cap$4.47B
P/E Ratio36.61
P/B Ratio3.27
P/S Ratio2.75
EPS (TTM)$1.96
52-Week High$85.03
52-Week Low$41.02
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE9.54%
ROA5.27%
ROCE16.62%
Gross Margin67.86%
Operating Margin14.39%
Net Margin7.47%
Debt/Equity0.28
Current Ratio1.33

Annual Financials (USD)

Metric20212022202320242025
Revenue$1.0B$1.0B$1.2B$1.3B$1.4B
Operating Profit$-1.0M$-77.0M$-68.0M$129.0M$199.0M
Net Profit$-136.0M$-86.0M$18.0M$63.0M$-242.0M
EPS$-2.68$-1.61$0.32$1.16$-4.45
Op Margin-0.1%-7.5%-5.9%10.3%14.4%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$2.2B$2.3B$2.4B$2.5B$2.6B
Total Liabilities$906.0M$1.1B$1.2B$1.2B$1.4B
Cash$208.0M$214.0M$267.0M$429.0M$636.0M
Borrowings$287.0M$580.0M$640.0M$677.0M$473.0M

Latest News

LIVN: Lowering target price to $83.00 Argus Research · Jul 15, 2026 LivaNova PLC (LIVN) Hit a 52 Week High, Can the Run Continue? Zacks · Jul 7, 2026 LivaNova to Announce Second-Quarter 2026 Results Business Wire · Jun 24, 2026 LivaNova Reports Improved OSA Outcomes With PolySync Programming Zacks · Jun 17, 2026 LivaNova's PolySync Algorithm Supports Improvement in Sleep Apnea Treatment Response Rate MT Newswires · Jun 16, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$103.0M$70.0M$75.0M$183.0M$254.0M
Investing Cash Flow$11.0M$-65.0M$-75.0M$-95.0M$-154.0M
Financing Cash Flow$-16.0M$-4.0M$-5.0M$-69.0M$-5.0M
Net Cash Flow$-45.0M$308.0M$62.0M$146.0M$-88.0M
Free Cash Flow$77.0M$43.0M$40.0M$136.0M$173.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.82
EV / EBITDA14.27
FCF Yield4.09%
Quick Ratio1.11
Interest Coverage4.06
Return 1Y82.09%
Return 3Y49.15%
Return 5Y-4.38%

Ownership

Insiders Held0.42%
Institutions Held112.89%
Institutions Float Held113.37%
Institutional HolderSharesReport Date
Blackrock Inc.7,138,9082026-03-31
Primecap Management Company4,207,0522026-03-31
FMR, LLC2,666,6742026-03-31
AQR Capital Management, LLC2,494,3722026-03-31
Millennium Management Llc2,438,6712026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ATEC $9.65 +3.54% -8.57 $1.48B 0.00%
CDTXCidara Therapeutics, Inc. $221.38 +0.00% -25.99 $5.61B 0.00%
HTFL $28.82 +5.99% -101.97 $2.49B 0.00%
IDYA $36.02 -2.05% -22.12 $3.42B 0.00%
IRON $73.86 -1.01% -9.08 $2.82B 0.00%

About LIVN

LIVN stock trades at $81.43 with a market capitalization of $4.47B. The stock is valued at a price-to-earnings (P/E) ratio of 36.61, price-to-book of 3.27, price-to-sales of 2.75. Over the past 52 weeks the stock has ranged between $41.02 and $85.03, and currently trades 4.2% below its 52-week high.

On profitability, LIVN generates a return on equity (ROE) of 9.54%, return on capital employed of 16.62%, an operating margin of 14.39%, a net profit margin of 7.47%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides